| 1 | JNJ | Johnson & Johnson | 8.08% |
| 2 | ABBV | AbbVie Inc. | 7.47% |
| 3 | PFE | Pfizer Inc. | 7.25% |
| 4 | MRK | Merck & Co., Inc. | 6.84% |
| 5 | BMY | Bristol-Myers Squibb Company | 6.12% |
| 6 | VTRS | Viatris Inc. | 4.42% |
| 7 | GILD | Gilead Sciences, Inc. | 3.97% |
| 8 | UTHR | United Therapeutics Corporation | 3.72% |
| 9 | BIIB | Biogen Inc. | 3.66% |
| 10 | AMGN | Amgen Inc. | 3.59% |
| 11 | ZTS | Zoetis Inc. | 3.49% |
| 12 | JAZZ | Jazz Pharmaceuticals plc | 3.10% |
| 13 | REGN | Regeneron Pharmaceuticals, Inc. | 3.09% |
| 14 | LLY | Eli Lilly and Company | 2.84% |
| 15 | ELAN | Elanco Animal Health Incorporated | 2.81% |
| 16 | MEDP | Medpace Holdings, Inc. | 2.66% |
| 17 | CRL | Charles River Laboratories International, Inc. | 2.06% |
| 18 | EXEL | Exelixis, Inc. | 2.00% |
| 19 | ILMN | Illumina, Inc. | 2.00% |
| 20 | OGN | Organon & Co. | 1.74% |
| 21 | HALO | Halozyme Therapeutics, Inc. | 1.59% |
| 22 | NBIX | Neurocrine Biosciences, Inc. | 1.58% |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 1.09% |
| 24 | ALKS | Alkermes plc | 0.96% |
| 25 | AMRX | Amneal Pharmaceuticals, Inc. | 0.95% |
| View FTXH holdings |